Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0012 Transporter Info
Gene Name ABCC3
Transporter Name Multidrug resistance-associated protein 3
Gene ID
8714
UniProt ID
O15438
Microbiota Influence of This DT (MBI)

Bacteria: Verrucomicrobiota

   Genus: Akkermansia

     Akkermansia muciniphila 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC3 expression in metabolic dysfunction-associated fatty liver disease condition [1]

Studied Phenotype

 Metabolic dysfunction-associated fatty liver disease [ICD11: DB95]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6 mice

Detailed Description

 The Akkermansia muciniphila ATCC BAA-835 has been reported to increase the expression of the drug transporter ABCC3.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 13 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of ABCC3 expression in the health condition [2] , [3]

Regulating Factor
2,3,7,8-tetrachlorodibenzofuran

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite 2,3,7,8-tetrachlorodibenzofuran generated from the metabolism of dietary dough pills by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 2

 Up regulating of ABCC3 expression in the health condition [2] , [3]

Regulating Factor
2,3,7,8-tetrachlorodibenzofuran

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite 2,3,7,8-tetrachlorodibenzofuran generated from the metabolism of dietary dough pills by the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 3

 Up regulating of ABCC3 expression in colon cancer condition [4]

Regulating Factor
Chenodeoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (HT-29)

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 4

 Up regulating of ABCC3 expression in colon cancer condition [4]

Regulating Factor
Deoxycholic acid

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Studied Tissue

 Colon

In Vitro Model

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 5

 Up regulating of ABCC3 expression in the health condition [5]

Regulating Factor
Lithocholic acid

Regulation Mechanism

 via modulation of the Nuclear receptor subfamily 1 group I member 3 (NR1I3) Transcription Factor Info

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite lithocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 6

 Up regulating of ABCC3 expression in the health condition [6] , [7]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 7

 Up regulating of ABCC3 expression in the health condition [6] , [7]

Regulating Factor
Bile acid (Cholic acid)

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 8

 Up regulating of ABCC3 expression in the health condition [6] , [7]

Regulating Factor
Bile acid (Deoxycholic acid)

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 9

 Up regulating of ABCC3 expression in the health condition [6] , [7]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 10

 Up regulating of ABCC3 expression in the health condition [6] , [7]

Regulating Factor
Bile acid (Lithocholic acid)

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 11

 Up regulating of ABCC3 expression in conventional mice compared with germ-free mice [8]

Regulation Mechanism

 via modulation of host microRNA (mmu-miR-665)

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Colon

In Vivo Model

 Swiss Webster germ-free/specific-pathogen-free mice

In Vitro Model

 Mouse leukemia cells (RAW 264.7)

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 12

 Up regulating of ABCC3 expression in conventional mice compared with germ-free mice [2] , [9]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Ileum

In Vivo Model

 Swiss Webster mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.

       Microbe Influence 13

 Up regulating of ABCC3 expression in conventional mice compared with germ-free mice [2] , [9]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 Swiss Webster mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter ABCC3.
References
1 Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021 Jan-Dec;13(1):1-19.
2 Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos. 2015 Oct;43(10):1505-21.
3 Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect. 2015 Jul;123(7):679-88.
4 Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein. Mol Pharm. 2018 Dec 3;15(12):5711-5727.
5 The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem. 2004 Nov 19;279(47):49517-22.
6 Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128.
7 Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1(Suppl 1):4523-30.
8 Microbiota modulate host gene expression via microRNAs. PLoS One. 2011 Apr 29;6(4):e19293.
9 Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013 Feb 5;17(2):225-35.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.